OrthoPediatrics sees Q4 revenue $52.7M, consensus $50.73M

The company said, “Generated preliminary unaudited fourth quarter 2024 net revenue of $52.7 million, representing growth of 40% compared to $37.6 million in the fourth quarter of 2023. Preliminary domestic fourth quarter net revenue is expected to be $42.9 million, representing 52% growth compared to the prior year period, and international net revenue is expected to be $9.8 million, representing 5% growth compared to the prior year period.”